DalsnaFinance › IPOs › Protagonist Therapeutics Inc › IPO
Protagonist Therapeutics, Inc completed its initial public offering on NASDAQ on August 11, 2016, pricing at $12.00 a share.
| Ticker | PTGX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | August 11, 2016 |
| Offering price | $12.00 |
| Shares offered | 7,500,000 |
| Total raised | $90M |
Protagonist Therapeutics, Inc sold 7,500,000 shares at $12.00 each on NASDAQ. Multiplied out, that is $90 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $90 million total recorded for the deal.
Protagonist Therapeutics, Inc — quote, profile and latest news →
Source: SEC EDGAR filings for Protagonist Therapeutics, Inc. This page is general information, not investment advice.